Tag: Michelle Maynard

Poster-Disease-modifying Therapy

Psoriasis in Multiple Sclerosis Patients Treated with Disease Modifying Therapies

Background: Psoriasis may be more common in people living with multiple sclerosis (PwMS) than in the general population. Some pathways...

Read More

Poster-Disease-modifying Therapy

Effect of Age on the Change of Lymphocytes and Immunoglobulins during Treatment with Ocrelizumab or Rituximab for Multiple Sclerosis and Related Disorders

Background: Depletion of B lymphocytes is a known therapeutic strategy for multiple sclerosis (MS) and related disorders. Ocrelizumab (OCR)...

Read More